Literature DB >> 22738689

Peripheral blood gene expression profile of atherosclerotic coronary artery disease in patients of different ethnicity in Malaysia.

Mohd Hafiz Ngoo Abdullah1, Zulhabri Othman, Hamdan Mohd Noor, Siti Suri Arshad, Ahmad Khairuddin Mohd Yusof, Rahman Jamal, Abdul Rashid Abdul Rahman.   

Abstract

The molecular basis of coronary artery disease (CAD) has been widely studied in the western world but there is no published work on the Malaysian population. This study looked at the global gene expression profiling of the peripheral blood of patients with CAD from the 3 main ethnic groups in Malaysia. Male subjects selected were based on angiographically confirmed CAD (≥50% stenosis) and normal control subjects (0% stenosis) with age range of 55.6±5.3 and 51.0±5.5 years, respectively. The global gene expression of 12 angiographically documented CAD patients and 11 matched control subjects were performed. The combined group samples identified 6 up regulated differential expression (DE) genes (GHRL, LTA, CBS, HP, ITGA2B, and OLR1) and 12 down regulated DE genes (IL18R1, ITGA2B, IL18RAP, HP, OLR1, SOD2 ITGB3, IL1B, MMP9, PLA2G7, UTS2, and CBS) to be involved in CAD at the fold change of 1.3 with fault discovery rate (FDR) of 1%. Three genes, MMP9, IL1B, and SOD2 were down regulated in all the 3 ethnic groups making them potential biomarker candidates for CAD across all three ethnicities. Further verification in a cohort study is needed.
Copyright © 2012 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22738689     DOI: 10.1016/j.jjcc.2012.05.009

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  8 in total

1.  Gene expression profiling of coronary artery disease and its relation with different severities.

Authors:  Shiridhar Kashyap; Sudeep Kumar; Vikas Agarwal; Durga P Misra; Shubha R Phadke; Aditya Kapoor
Journal:  J Genet       Date:  2018-09       Impact factor: 1.166

Review 2.  Transcriptomic Signature of Atherosclerosis in the Peripheral Blood: Fact or Fiction?

Authors:  Hsiao-Huei Chen; Alexandre F R Stewart
Journal:  Curr Atheroscler Rep       Date:  2016-12       Impact factor: 5.113

3.  In Vivo and In Vitro Analysis in Coronary Artery Disease Related to Type 2 Diabetes.

Authors:  Teresa Infante; Ernesto Forte; Marco Aiello; Marco Salvatore; Carlo Cavaliere
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-21       Impact factor: 5.555

4.  Superoxide Dismutase Isoenzymes Gene Expression in Peripheral Blood Mononuclear Cells in Patients with Coronary Artery Disease.

Authors:  Ana Ninić; Nataša Bogavac-Stanojević; Miron Sopić; Jelena Munjas; Jelena Kotur-Stevuljević; Milica Miljković; Tamara Gojković; Dimitra Kalimanovska-Oštrić; Vesna Spasojević-Kalimanovska
Journal:  J Med Biochem       Date:  2019-05-11       Impact factor: 3.402

5.  PR3 levels are impaired in plasma and PBMCs from Arabs with cardiovascular diseases.

Authors:  Abdelkrim Khadir; Dhanya Madhu; Sina Kavalakatt; Preethi Cherian; Monira Alarouj; Abdullah Bennakhi; Jehad Abubaker; Ali Tiss; Naser Elkum
Journal:  PLoS One       Date:  2020-01-14       Impact factor: 3.240

Review 6.  Circulating Leukocytes and Oxidative Stress in Cardiovascular Diseases: A State of the Art.

Authors:  Speranza Rubattu; Maurizio Forte; Salvatore Raffa
Journal:  Oxid Med Cell Longev       Date:  2019-10-15       Impact factor: 6.543

7.  Rare variants in previously identified linkage regions associated with carotid plaque in Dominican Republic families.

Authors:  Nicole D Dueker; Ashley Beecham; Liyong Wang; Chuanhui Dong; Ralph L Sacco; Susan H Blanton; Tatjana Rundek
Journal:  PLoS One       Date:  2022-01-12       Impact factor: 3.240

8.  DENND5B Regulates Intestinal Triglyceride Absorption and Body Mass.

Authors:  Scott M Gordon; Edward B Neufeld; Zhihong Yang; Milton Pryor; Lita A Freeman; Xiao Fan; Iftikhar J Kullo; Leslie G Biesecker; Alan T Remaley
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.